Medical spinoffs down but not out

These three medical products makers (including Kenvue, see box) have struggled as independent firms. While all three have solid prospects, embecta is the only one we see as a buy right now.
EMBECTA CORP. $16 is a spinoff buy. The company (Nasdaq symbol EMBC; Manufacturing & Industry sector;… Read More

Tap into key trends with these healthcare ETFs

The underlying growth trends for healthcare remain strong as the global population grows older and emerging economies become wealthier.
Meanwhile, new technologies and artificial intelligence (AI) will serve to boost the already-strong prospects of healthcare stocks by improving the management of patient diagnostics, administrative processes, and… Read More